Correlation of dynamic contrast-enhanced ultrasonography and the Ki-67 labelling index in pancreatic ductal adenocarcinoma

被引:0
|
作者
Lin, Xiao-Jing [1 ]
Zhu, Shu [1 ]
Wang, Dan [1 ]
Chen, Jing-Yuan [1 ]
Wei, Su-Xian [1 ]
Chen, Shi-Yun [1 ]
Luo, Hong-Chang [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Med Ultrasound, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China
关键词
Pancreatic ductal adenocarcinoma; Dynamic contrast-enhanced ultrasonography; Ki-67; antigen; Quantitative analysis; Prognostic situation; MICROVASCULAR INVASION; ULTRASOUND; DIAGNOSIS;
D O I
10.3748/wjg.v30.i44.4697
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant and aggressive tumor, and high Ki-67 expression indicates poor histological differentiation and prognosis. Therefore, one of the challenges in diagnosing preoperatively patients with PDAC is predicting the degree of malignancy. Dynamic contrast-enhanced ultrasonography (DCE-US) plays a crucial role in abdominal tumor diagnosis, and can adequately show the microvascular composition within the tumors. However, the relationship between DCE-US and the Ki-67 labelling index remains unclear at the present time. AIM To predict the correlation between Ki-67 expression and the parameters of DCE-US. METHODS Patients with PDAC who underwent DCE-US were retrospectively analyzed. Patients who had received any treatment (radiotherapy or chemotherapy) prior to DCE-US; had incomplete clinical, imaging, or pathologic information; and had poor-quality image analysis were excluded. Correlations between Ki-67 expression and the parameters of DCE-US in patients with PDAC were assessed using Spearman's rank correlation analysis. The diagnostic performances of these parameters in high Ki-67 expression group were evaluated according to receiver operating characteristic curve. RESULTS Based on the Ki-67 labelling index, 30 patients were divided into two groups, i.e., the high expression group and the low expression group. Among the relative quantitative parameters between the two groups, relative half-decrease time (rHDT), relative peak enhancement, relative wash-in perfusion index and relative wash-in rate were significantly different between two groups (P = 0.018, P = 0.025, P = 0.028, P = 0.035, respectively). The DCE-US parameter rHDT was moderately correlated with Ki-67 expression, and rHDT >= 1.07 was more helpful in accurately diagnosing high Ki-67 expression, exhibiting a sensitivity and specificity of 53.8% and 94.1%, respectively. CONCLUSION One parameter of DCE-US, rHDT, correlates with high Ki-67 expression. It demonstrates that parameters obtained noninvasively by DCE-US could better predict Ki-67 expression in PDAC preoperatively.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Prediction of the Ki-67 marker index in hepatocellular carcinoma based on Dynamic Contrast-Enhanced Ultrasonography with Sonazoid
    Zhe Huang
    PingPing Zhou
    ShanShan Li
    Kaiyan Li
    Insights into Imaging, 13
  • [2] Prediction of the Ki-67 marker index in hepatocellular carcinoma based on Dynamic Contrast-Enhanced Ultrasonography with Sonazoid
    Huang, Zhe
    Zhou, PingPing
    Li, ShanShan
    Li, Kaiyan
    INSIGHTS INTO IMAGING, 2022, 13 (01)
  • [3] Prognostic impact of Ki-67 proliferative index in resectable pancreatic ductal adenocarcinoma
    Pergolini, I
    Crippa, S.
    Pagnanelli, M.
    Belfiori, G.
    Pucci, A.
    Partelli, S.
    Rubini, C.
    Castelli, P.
    Zamboni, G.
    Falconi, M.
    BJS OPEN, 2019, 3 (05): : 646 - 655
  • [4] Correlation between Ki-67 Expression and Hemodynamics of Contrast-Enhanced Ultrasound in Patients with Breast Infiltrative Ductal Carcinoma
    Du, Rui
    Zhang, Hao
    Shu, Weiwei
    Chen, Baoding
    Li, Yuefeng
    Zhang, Xin
    Wu, Xincai
    Wang, Zhongqun
    AMERICAN SURGEON, 2018, 84 (06) : 856 - 861
  • [5] Histological influence on contrast-enhanced CT of pancreatic ductal adenocarcinoma
    Demachi, H
    Matsui, B
    Kobayashi, S
    Akakura, Y
    Konishi, K
    Tsuji, M
    Miwa, A
    Miyata, S
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1997, 21 (06) : 980 - 985
  • [6] Ki-67 labelling index in human brain tumours
    Niemiec, J
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2001, 39 (03): : 259 - 262
  • [7] Is the Ki-67 labelling index ready for clinical use?
    Jonat, W.
    Arnold, N.
    ANNALS OF ONCOLOGY, 2011, 22 (03) : 500 - 502
  • [8] A case of stage IA pancreatic ductal adenocarcinoma accompanied with focal pancreatitis demonstrated by contrast-enhanced ultrasonography
    Fukuda, Junko
    Tanaka, Sachiko
    Ishida, Nobuko
    Ioka, Tatsuya
    Ikezawa, Kenji
    Takakura, Rena
    Nakao, Miho
    Ohkawa, Kazuyoshi
    Katayama, Kazuhiro
    Nagata, Shigenori
    JOURNAL OF MEDICAL ULTRASONICS, 2018, 45 (04) : 617 - 622
  • [9] A case of stage IA pancreatic ductal adenocarcinoma accompanied with focal pancreatitis demonstrated by contrast-enhanced ultrasonography
    Junko Fukuda
    Sachiko Tanaka
    Nobuko Ishida
    Tatsuya Ioka
    Kenji Ikezawa
    Rena Takakura
    Miho Nakao
    Kazuyoshi Ohkawa
    Kazuhiro Katayama
    Shigenori Nagata
    Journal of Medical Ultrasonics, 2018, 45 : 617 - 622
  • [10] Correlation of Perfusion Metrics with Ki-67 Proliferation Index and Axillary Involvement as a Prognostic Marker in Breast Carcinoma Cases: A Dynamic Contrast-Enhanced Perfusion MRI Study
    Uncu, Ulas Yalim
    Aksu, Sibel Aydin
    DIAGNOSTICS, 2023, 13 (20)